Click on the icon to read the Summer 2012 Newsletter.

Summer 2012
Search
Check Out The Pulse of Catholic Medicine
-
Catholic Medical Groups Urge FDA to Reinstate Safeguards on Abortion Pill Mifepristone
The Catholic Medical Association (CMA), alongside several prominent Catholic health and ethics organizations, has formally requested that the U.S. Food and Drug Administration (FDA) conduct a comprehensive review of the abortion drug mifepristone, citing rising safety concerns—especially in cases involving telemedicine. In a joint letter addressed to FDA Commissioner Dr. Marty Makary, the coalition urges…